Daniel Zamith-Miranda
Overview
Explore the profile of Daniel Zamith-Miranda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
491
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alves V, Zamith-Miranda D, Frases S, Nosanchuk J
J Fungi (Basel)
. 2025 Feb;
11(2).
PMID: 39997385
Metabolomics has emerged as a transformative tool in the study of microbes, including pathogenic fungi, facilitating the identification of unique metabolic profiles that elucidate their pathogenic mechanisms, host interactions, and...
2.
Kwaku G, Jensen K, Simaku P, Floyd D, Saelens J, Reardon C, et al.
bioRxiv
. 2025 Jan;
PMID: 39803513
Microbial pathogens generate extracellular vesicles (EVs) for intercellular communication and quorum sensing. Microbial EVs also induce inflammatory pathways within host innate immune cells. We previously demonstrated that EVs secreted by...
3.
Honorato L, Artunduaga Bonilla J, Ribeiro da Silva L, Kornetz J, Zamith-Miranda D, Valdez A, et al.
Virulence
. 2024 Oct;
15(1):2413329.
PMID: 39370781
The urgency surrounding as a public health threat is highlighted by both the Center for Disease Control (CDC) and World Health Organization (WHO) that categorized this species as a priority...
4.
Brown Harding H, Kwaku G, Reardon C, Khan N, Zamith-Miranda D, Zarnowski R, et al.
Nat Microbiol
. 2024 Jan;
9(1):95-107.
PMID: 38168615
The host type I interferon (IFN) pathway is a major signature of inflammation induced by the human fungal pathogen, Candida albicans. However, the molecular mechanism for activating this pathway in...
5.
Valdez A, de Souza T, Artunduaga Bonilla J, Zamith-Miranda D, Piffer A, Araujo G, et al.
J Fungi (Basel)
. 2023 Nov;
9(11).
PMID: 37998859
is the causative agent of histoplasmosis. Treating this fungal infection conventionally has significant limitations, prompting the search for alternative therapies. In this context, fungal extracellular vesicles (EVs) hold relevant potential...
6.
Chechi J, da Costa F, Figueiredo J, de Souza C, Valdez A, Zamith-Miranda D, et al.
Expert Rev Vaccines
. 2023 Nov;
22(1):1136-1153.
PMID: 37936254
Introduction: Fungal infections are caused by a broad range of pathogenic fungi that are found worldwide with different geographic distributions, incidences, and mortality rates. Considering that there are relatively few...
7.
Erives V, Munzen M, Zamith-Miranda D, Hernandez H, Manepalli S, Nguyen L, et al.
Infect Immun
. 2023 Oct;
91(11):e0036623.
PMID: 37877710
No abstract available.
8.
Valdez A, Zamith-Miranda D, Nimrichter L, Nosanchuk J
Future Microbiol
. 2023 Sep;
18:1007-1011.
PMID: 37721209
No abstract available.
9.
Liu S, Zamith-Miranda D, Almeida-Paes R, da Silva L, Nacharaju P, Nosanchuk J
Fungal Biol
. 2023 Jul;
127(7-8):1224-1230.
PMID: 37495312
Fungal diseases are a leading threat to human health, especially in individuals with compromised immunity. Although there have been recent important advances in antifungal drug development, antifungal resistance, drug-drug interactions...
10.
Smith D, Mudrak N, Zamith-Miranda D, Honorato L, Nimrichter L, Chrissian C, et al.
J Fungi (Basel)
. 2022 Oct;
8(10).
PMID: 36294632
is a recently emerged global fungal pathogen, which causes life-threatening infections, often in healthcare settings. infections are worrisome because the fungus is often resistant to multiple antifungal drug classes. Furthermore,...